Case Overview

The Parties

The Patents at Issue

This landmark case involved eight patents covering critical microprocessor technologies across a wide range of semiconductor innovations:

• • U.S. Patent No. 7,706,207 — Memory/data path architecture
• • U.S. Patent No. 8,004,922 — Semiconductor timing and signal integrity
• • U.S. Patent No. 8,020,014 — Power management systems
• • U.S. Patent No. 7,268,588 — Circuit design and integration
• • U.S. Patent No. 7,675,806 — On-chip interconnect technology
• • U.S. Patent No. 7,709,303 — Semiconductor fabrication processes
• • U.S. Patent No. 8,268,672 — Chip packaging and integration
• • U.S. Patent No. 8,566,836 — Memory interface architecture

The Accused Products

VLSI accused a broad range of Intel products, including Atom microprocessors, Core i3/i5/i7 processors, Xeon E3/E5/E7 server processors, Intel’s Embedded Multi-die Interconnect Bridge (EMIB) technology, Stratix 10 FPGAs, and Turbo Boost Max Technology 3.0 — underscoring the sweeping commercial scope of VLSI’s infringement allegations.

Legal Representation

VLSI retained a formidable plaintiff-side team led by Irell & Manella LLP, Kirkland & Ellis LLP, Bunsow DeMory LLP, and Dickinson Wright PLLC, with prominent attorneys including Morgan Chu and Benjamin Hattenbach. Intel was represented by WilmerHale LLP, Gibson, Dunn & Crutcher LLP, and K&L Gates LLP, fielding counsel including William F. Lee and Joseph J. Mueller.

Litigation Timeline & Procedural History

VLSI filed suit in the Northern District of California — a technically sophisticated venue well-suited to complex semiconductor patent disputes — on October 2, 2017. The case proceeded at first-instance (district court) level through nearly six and a half years of litigation before final judgment on March 29, 2024.

Key procedural milestones included extensive cross-motions for summary judgment, which proved dispositive on multiple patent counts. The court’s order granting in part and denying in part the parties’ summary judgment motions (ECF Nos. 772 & 778) resolved the infringement questions on U.S. Patent Nos. 8,004,922 and 8,566,836 in Intel’s favor. A separate motion to dismiss Intel’s license counterclaim (ECF No. 903) was granted in VLSI’s favor. Remaining claims were resolved through party stipulations and mootness findings (ECF Nos. 801 & 807).

The case’s 2,370-day duration reflects the complexity inherent in multi-patent semiconductor litigation involving dozens of accused products, extensive claim construction proceedings, and high-stakes summary judgment practice on both validity and infringement grounds.

The Verdict & Legal Analysis

Outcome

The Northern District of California entered a split final judgment resolving all counts in this action:

Intel prevailed on:

• • VLSI’s Fifth Count — Infringement of U.S. Patent No. 8,004,922
• • VLSI’s Eighth Count — Infringement of U.S. Patent No. 8,566,836
• • Intel’s Tenth Counterclaim — Invalidity of U.S. Patent No. 8,004,922

VLSI prevailed on:

• • Intel’s Seventeenth Counterclaim for Declaratory Judgment of License — dismissed without prejudice to refiling in a proper forum

All remaining claims and counterclaims were dismissed. No damages award or injunctive relief was reported in the final judgment.

Verdict Cause Analysis

The resolution of the two pivotal infringement counts — U.S. Patent Nos. 8,004,922 and 8,566,836 — at the summary judgment stage rather than at trial is strategically significant. Summary judgment victories for defendants in patent cases typically require either clear non-infringement as a matter of law following claim construction, or successful invalidity showings on undisputed facts. Here, Intel secured a finding of invalidity on the ‘922 patent alongside non-infringement, a dual outcome that eliminated any appellate risk of the patent surviving on remand.

VLSI’s defeat on its license counterclaim defense — specifically, the court’s dismissal of Intel’s declaratory judgment claim regarding a license to VLSI’s patents — signals the court’s determination that Intel had not established licensing entitlements in this forum. The “without prejudice” qualifier preserves Intel’s ability to pursue that argument elsewhere, suggesting the dismissal was jurisdictional or procedural rather than substantive.

Legal Significance

Several doctrinal considerations emerge from this outcome. First, the invalidity finding on U.S. Patent No. 8,004,922 carries potential collateral estoppel weight in any parallel or subsequent proceedings involving that patent. Patent assertion entities relying on the same portfolio in multi-district litigation strategies must account for this risk. Second, the dismissal of a license-based declaratory judgment counterclaim reinforces the importance of establishing proper forum and factual predicates for such defensive claims before asserting them in infringement litigation.

The case also illustrates the viability of summary judgment as a trial-avoidance strategy in technically complex semiconductor patent cases, particularly when defendants can mount strong claim construction and invalidity arguments.

Strategic Takeaways

For patent holders: Multi-patent assertion strategies spread litigation risk but also create compounded vulnerability at summary judgment. VLSI’s experience underscores the importance of curating asserted claims to ensure each patent can withstand rigorous invalidity scrutiny before litigation.

For accused infringers: Intel’s success on summary judgment demonstrates that investing in early invalidity analysis and parallel USPTO proceedings (IPR/PGR) creates viable pathways to case resolution without trial exposure. License counterclaims require careful jurisdictional and contractual analysis before assertion.

For R&D teams: Products accused here — Core, Xeon, Atom, and EMIB technologies — represent Intel’s entire commercial microprocessor ecosystem. This broad accusation pattern highlights the freedom-to-operate (FTO) risks that inherited patent portfolios from legacy semiconductor companies (NXP, Philips lineage) continue to pose to chip manufacturers.

Industry & Competitive Implications

VLSI v. Intel is part of a broader wave of semiconductor patent assertions by NPEs holding portfolios acquired from divested legacy chip businesses. The case reflects an industry-wide licensing pressure dynamic in which major foundries and fabless manufacturers face multi-front litigation from entities monetizing decades-old semiconductor IP.

Intel’s ultimate success on the two most hotly contested patents — combined with the lengthy litigation timeline — sends a clear message: well-resourced defendants can effectively neutralize NPE assertions through persistent invalidity and claim construction challenges, even at significant cost and duration. For Intel, the resolution avoids any damages exposure on these specific patents while preserving its commercial product roadmap.

For the broader semiconductor industry, this outcome reinforces the value of proactive IPR petitions at the Patent Trial and Appeal Board as a companion strategy to district court litigation. Companies facing similarly broad NPE assertions in the Northern District of California should monitor this case’s claim construction orders as persuasive authority in related proceedings.

Licensing practitioners should note that VLSI’s parallel litigations against Intel in other jurisdictions — including *VLSI Technology v. Intel* in the Western District of Texas — produced different outcomes, illustrating the significant impact of venue selection on semiconductor patent litigation results.